Published in Invest Ophthalmol Vis Sci on October 24, 2008
The TAg-RB murine retinoblastoma cell of origin has immunohistochemical features of differentiated Muller glia with progenitor properties. Invest Ophthalmol Vis Sci (2011) 2.03
Current update on retinoblastoma. Int Ophthalmol Clin (2011) 1.10
Gelatinase expression in retinoblastoma: modulation of LH(BETA)T(AG) retinal tumor development by anecortave acetate. Invest Ophthalmol Vis Sci (2010) 0.89
Intravitreal and subconjunctival melphalan for retinoblastoma in transgenic mice. J Ophthalmol (2014) 0.88
Regional and temporal differences in gene expression of LH(BETA)T(AG) retinoblastoma tumors. Invest Ophthalmol Vis Sci (2011) 0.85
Focal, periocular delivery of 2-deoxy-D-glucose as adjuvant to chemotherapy for treatment of advanced retinoblastoma. Invest Ophthalmol Vis Sci (2010) 0.84
Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway. BMC Cancer (2010) 0.83
Advanced retinoblastoma treatment: targeting hypoxia by inhibition of the mammalian target of rapamycin (mTOR) in LH(BETA)T(AG) retinal tumors. Clin Ophthalmol (2011) 0.80
Retinoblastoma treatment: utilization of the glycolytic inhibitor, 2-deoxy-2-fluoro-D-glucose (2-FG), to target the chemoresistant hypoxic regions in LH(BETA)T(AG) retinal tumors. Invest Ophthalmol Vis Sci (2012) 0.78
Microvessel Density Is Associated with VEGF and α-SMA Expression in Different Regions of Human Gastrointestinal Carcinomas. Cancers (Basel) (2011) 0.77
Residual intraretinal retinoblastoma after chemoreduction failure. Arch Ophthalmol (2012) 0.76
Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LH(BETA)T(AG) retinal tumors. Clin Ophthalmol (2012) 0.75
A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study. Am J Ophthalmol (2009) 5.41
Acute endophthalmitis following intravitreal triamcinolone acetonide injection. Am J Ophthalmol (2003) 4.78
Off-label use of intravitreal bevacizumab (Avastin) for salvage treatment in progressive threshold retinopathy of prematurity. Retina (2008) 3.12
Endophthalmitis after intravitreal vascular [corrected] endothelial growth factor antagonists: a six-year experience at a university referral center. Retina (2011) 2.97
Retained lens fragments after cataract surgery: outcomes of same-day versus later pars plana vitrectomy. Am J Ophthalmol (2013) 2.13
Novel method for analyzing snellen visual acuity measurements. Retina (2010) 1.98
Factors associated with reduced visual acuity during long-term follow-up of patients with idiopathic central serous chorioretinopathy. Retina (2002) 1.86
Delayed- versus acute-onset endophthalmitis after cataract surgery. Am J Ophthalmol (2011) 1.83
Clinical analysis of the effect of intraarterial cytoreductive chemotherapy in the treatment of lacrimal gland adenoid cystic carcinoma. Am J Ophthalmol (2006) 1.80
Acute-onset endophthalmitis after clear corneal cataract surgery (1996-2005). Clinical features, causative organisms, and visual acuity outcomes. Ophthalmology (2007) 1.79
Clinical and pathologic characteristics of biopsy-proven iris melanoma: a multicenter international study. Arch Ophthalmol (2011) 1.78
Pars plana vitrectomy with internal limiting membrane peeling for diabetic macular edema. Retina (2008) 1.75
Adverse effects of smoking on patients with ocular inflammation. Br J Ophthalmol (2010) 1.61
Impact of ocular surface symptoms on quality of life in a United States veterans affairs population. Am J Ophthalmol (2012) 1.53
Endophthalmitis caused by Mycobacterium chelonae: selection of antibiotics and outcomes of treatment. Arch Ophthalmol (2003) 1.44
Mucosa-associated lymphoid tissue lymphoma with intraocular involvement. Retina (2005) 1.42
Supraselective intra-arterial chemotherapy: evaluation of treatment-related complications in advanced retinoblastoma. Clin Ophthalmol (2011) 1.38
Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors. J Neurosurg (2011) 1.37
Reproducibility of pattern electroretinogram in glaucoma patients with a range of severity of disease with the new glaucoma paradigm. Ophthalmology (2007) 1.35
Use of ultra-high-resolution optical coherence tomography to detect in vivo characteristics of Descemet's membrane in Fuchs' dystrophy. Ophthalmology (2010) 1.33
The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: IV. Local treatment failure and enucleation in the first 5 years after brachytherapy. COMS report no. 19. Ophthalmology (2002) 1.29
Management of dislocated intraocular lenses. Ophthalmology (2008) 1.29
The role of aging, high fat diet and blue light exposure in an experimental mouse model for basal laminar deposit formation. Exp Eye Res (2002) 1.28
Update on bacterial conjunctivitis in South Florida. Ophthalmology (2007) 1.27
Endophthalmitis caused by Mycobacterium chelonae abscessus after intravitreal injection of triamcinolone. Arch Ophthalmol (2003) 1.26
Ciliary body medulloepithelioma: four cases associated with pleuropulmonary blastoma--a report from the International Pleuropulmonary Blastoma Registry. Br J Ophthalmol (2010) 1.25
Long-term follow-up of conjunctival and corneal intraepithelial neoplasia treated with topical interferon alfa-2b. Ophthalmology (2008) 1.24
Visual recovery after scleral buckling procedure for retinal detachment. Ophthalmology (2006) 1.21
Scanning laser polarimetry with variable corneal compensation and optical coherence tomography in normal and glaucomatous eyes. Am J Ophthalmol (2003) 1.17
Intravitreal injection analysis at the Bascom Palmer Eye Institute: evaluation of clinical indications for the treatment and incidence rates of endophthalmitis. Clin Ophthalmol (2010) 1.14
Targeting hypoxia, a novel treatment for advanced retinoblastoma. Invest Ophthalmol Vis Sci (2008) 1.12
Depression, post-traumatic stress disorder, and dry eye syndrome: a study utilizing the national United States Veterans Affairs administrative database. Am J Ophthalmol (2012) 1.12
Combined phacoemulsification and sutureless 23-gauge pars plana vitrectomy for complex vitreoretinal diseases. Br J Ophthalmol (2010) 1.12
Retinal tumor imaging and volume quantification in mouse model using spectral-domain optical coherence tomography. Opt Express (2009) 1.11
Predictors of ocular surface squamous neoplasia recurrence after excisional surgery. Ophthalmology (2012) 1.11
Outcomes of surgery for retinal detachment associated with proliferative vitreoretinopathy using perfluoro-n-octane: a multicenter study. Am J Ophthalmol (2003) 1.11
Current update on retinoblastoma. Int Ophthalmol Clin (2011) 1.10
Retinoblastoma tumor vessel maturation impacts efficacy of vessel targeting in the LH(BETA)T(AG) mouse model. Invest Ophthalmol Vis Sci (2007) 1.10
Comparison of intravitreal bevacizumab followed by ranibizumab for the treatment of neovascular age-related macular degeneration. Retina (2009) 1.09
Immediate postoperative use of a topical agent to prevent intraocular pressure elevation after pars plana vitrectomy with gas tamponade. Arch Ophthalmol (2004) 1.08
Antiangiogenic activity of 2-deoxy-D-glucose. PLoS One (2010) 1.08
Predicting the progression of geographic atrophy in age-related macular degeneration with SD-OCT en face imaging of the outer retina. Ophthalmic Surg Lasers Imaging Retina (2013) 1.08
Efficacy of various drugs in the prevention of posterior capsule opacification: experimental study of rabbit eyes. J Cataract Refract Surg (2004) 1.07
An atypical presentation of adenoid cystic carcinoma of the lacrimal gland. Am J Ophthalmol (2006) 1.07
Clinical features and outcomes of pars plana vitrectomy in patients with retained lens fragments. Ophthalmology (2003) 1.06
Spectral domain optical coherence tomography in a murine retinal detachment model. Exp Eye Res (2010) 1.06
Corneal thickness indices discriminate between keratoconus and contact lens-induced corneal thinning. Ophthalmology (2002) 1.05
Macular retinoblastoma: evaluation of tumor control, local complications, and visual outcomes for eyes treated with chemotherapy and repetitive foveal laser ablation. Ophthalmology (2006) 1.05
One-year safety and efficacy of intravitreal triamcinolone acetonide for the management of macular edema secondary to central retinal vein occlusion. Retina (2006) 1.05
Advanced Coats' disease. Management with repetitive aggressive laser ablation therapy. Retina (2008) 1.04
Ocular surface parameters in older male veterans. Invest Ophthalmol Vis Sci (2013) 1.04
Infiltration of proinflammatory m1 macrophages into the outer retina precedes damage in a mouse model of age-related macular degeneration. Int J Inflam (2013) 1.04
Visual and anatomic outcomes with or without surgery in persistent fetal vasculature. Ophthalmology (2010) 1.03
Safety and efficacy of intravitreal bevacizumab (avastin) for the management of branch and hemiretinal vein occlusion. Retina (2009) 1.02
Outcomes of complex retinal detachment repair using 1000- vs 5000-centistoke silicone oil. Arch Ophthalmol (2005) 1.02
Outcomes and complications associated with giant retinal tear management using perfluoro-n-octane. Ophthalmology (2002) 1.02
Comparison of predictions made by the intraocular lens master and ultrasound biometry. Arch Ophthalmol (2008) 1.00
Retinal detachment in eyes undergoing pars plana vitrectomy for removal of retained lens fragments. Ophthalmology (2003) 1.00
Baerveldt glaucoma implant in the management of refractory childhood glaucomas. Ophthalmology (2004) 0.99
MHC class II-transduced tumor cells originating in the immune-privileged eye prime and boost CD4(+) T lymphocytes that cross-react with primary and metastatic uveal melanoma cells. Cancer Res (2007) 0.98
Distinguishing torpedo maculopathy from similar lesions of the posterior segment. Ophthalmic Surg Lasers Imaging Retina (2014) 0.98
Endophthalmitis caused by staphylococcus epidermidis: in vitro antibiotic susceptibilities and clinical outcomes. Ophthalmic Surg Lasers Imaging (2007) 0.97
Clinicopathologic review of enucleated eyes after intra-arterial chemotherapy with melphalan for advanced retinoblastoma. Arch Ophthalmol (2010) 0.97
Effect of a Mediterranean dietary pattern and vitamin D levels on Dry Eye syndrome. Cornea (2014) 0.96
Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion. Retina (2008) 0.96
Management of retinal detachment when no break is found. Ophthalmology (2006) 0.96
Anecortave acetate as single and adjuvant therapy in the treatment of retinal tumors of LH(BETA)T(AG) mice. Invest Ophthalmol Vis Sci (2006) 0.95
Retinoblastoma treatment burden and economic cost: impact of age at diagnosis and selection of primary therapy. Clin Ophthalmol (2012) 0.95
Inter- and intrarater reliability in computed axial tomographic grading of splenic injury: why so many grading scales? J Trauma (2004) 0.95
Increased hypoxia following vessel targeting in a murine model of retinoblastoma. Invest Ophthalmol Vis Sci (2009) 0.95
Incidence of cataract extraction after diabetic vitrectomy. Retina (2004) 0.95
Quality of life after iodine 125 brachytherapy vs enucleation for choroidal melanoma: 5-year results from the Collaborative Ocular Melanoma Study: COMS QOLS Report No. 3. Arch Ophthalmol (2006) 0.93
Endophthalmitis caused by Bacillus species. Am J Ophthalmol (2008) 0.93
Comparison of retinoblastoma reduction for chemotherapy vs external beam radiotherapy. Arch Ophthalmol (2003) 0.93
Retinoblastoma. Curr Opin Ophthalmol (2013) 0.92
Development of multiple subretinal hemorrhages during diode laser supplementation for retinopathy of prematurity. J Pediatr Ophthalmol Strabismus (2006) 0.92
Mechanism of retinoblastoma tumor cell death after focal chemotherapy, radiation, and vascular targeting therapy in a mouse model. Invest Ophthalmol Vis Sci (2007) 0.92
Uveal melanoma presenting as acute angle-closure glaucoma: report of two cases. Am J Ophthalmol (2003) 0.92
Combined Baerveldt glaucoma drainage implant and trabeculectomy with mitomycin C for refractory glaucoma. J Glaucoma (2002) 0.92
Simultaneous presentation of retinopathy of prematurity and bilateral familial retinoblastoma in a premature infant. J Pediatr Ophthalmol Strabismus (2003) 0.91
Pars plana lensectomy and intraocular lens implantation in pediatric radiation-induced cataracts in retinoblastoma. Ophthalmology (2005) 0.91
Lontophoresis for the treatment of paecilomyces keratitis. Cornea (2002) 0.90
Early onset endophthalmitis caused by Aspergillus species following cataract surgery. Am J Ophthalmol (2006) 0.90
Phosphorylated neurofilament heavy chain correlations to visual function, optical coherence tomography, and treatment. Mult Scler Int (2011) 0.90
Increased incidence of sterile endophthalmitis after intravitreal triamcinolone acetonide in spring 2006. Retina (2009) 0.90
Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration. Clin Ophthalmol (2010) 0.90